9MW3811

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 9MW3811, covering 2025-12-09 to 2025-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Pharmacokinetic Properties of 9MW3811 in Healthy Subjects [Phase 1]

See pricing